Pubblicazioni ufficiali BioSenic SA

Azioni

Mercato chiuso - Euronext Bruxelles Altri mercati azionari 16:12:25 15/05/2024			Variaz. 5gg	Var. 1 gen.
0,0147 ^EUR	+2,08%		+5,76%	-75,98%

12/03	Biosenic S.A. rilascia i dettagli dell'approccio di somministrazione ottimizzato in vista della sperimentazione di Fase 3 di OATO per la malattia cronica del trapianto e dell'ospite (Graft-Versus-Host Disease)	CI
30/01	L'unità BioSenic ottiene un brevetto canadese per la piattaforma terapeutica	MT

3rd quarter turnover	21/10/22	CO
3rd quarter turnover	21/10/22	CO
Threshold crossings	11/10/22	CO
Threshold crossings	11/10/22	CO
Extraordinary general shareholder meeting	06/10/22	CO
Extraordinary general shareholder meeting	06/10/22	CO
Monthly statement on voting rights	30/09/22	CO
Monthly statement on voting rights	30/09/22	CO
Half-year report	07/09/22	CO
1st-half-year results	07/09/22	CO
1st-half-year results	07/09/22	CO
Half-year report	07/09/22	CO
Extraordinary general shareholder meeting	05/09/22	CO
Extraordinary general shareholder meeting	05/09/22	CO
Threshold crossings	31/08/22	CO
Monthly statement on voting rights	31/08/22	CO
Monthly statement on voting rights	31/08/22	CO
Extraordinary general shareholder meeting	26/08/22	CO
Extraordinary general shareholder meeting	26/08/22	CO
Admission of new securities	10/08/22	CO
Admission of new securities	10/08/22	CO
Monthly statement on voting rights	29/07/22	CO
Security operations	29/07/22	CO
Security operations	29/07/22	CO
Monthly statement on voting rights	29/07/22	CO